The role of the prion protein membrane anchor in prion infection

Prion

Volumn 3, Issue 3, 2009, Pages

  Priola, Suzette A ^a   McNally, Kristin L ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

GPI anchor; Prion; Prion spread; PrP; Scrapie

Indexed keywords

GLYCOSYLPHOSPHATIDYLINOSITOL; PRION PROTEIN; EPITOPE;

BRAIN; CARBOXY TERMINAL SEQUENCE; CELL CONTACT; CELL DIVISION; CELL MEMBRANE; CELL SURFACE; CELL TYPE; CENTRAL NERVOUS SYSTEM; CREUTZFELDT JAKOB DISEASE; EXTRACELLULAR MATRIX; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; NOTE; PATHOGENESIS; PATHOLOGY; PRION; PRION DISEASE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SCRAPIE; SHEEP; SIGNAL TRANSDUCTION; VIRUS INFECTIVITY; ANIMAL; CHEMISTRY; DISEASE MODEL; HUMAN; INTRACELLULAR MEMBRANE; METABOLISM; MOUSE; PATHOPHYSIOLOGY; REVIEW; TIME;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; EPITOPES; GLYCOSYLPHOSPHATIDYLINOSITOLS; HUMANS; INTRACELLULAR MEMBRANES; MICE; PRION DISEASES; PRIONS; SCRAPIE; TIME FACTORS;

EID: 70349760839     PISSN: 19336896     EISSN: 1933690X     Source Type: Journal    
DOI: 10.4161/pri.3.3.9771     Document Type: Note

References (42)

1. Stahl N, Borchelt DR, Prusiner SB. Differential release of cellular and scrapie prion proteins from cellular membranes by phosphatidylinositol-specific phospholipase C. Biochemistry 1990; 29:5405-12.
2. Caughey B, Raymond GJ. The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase-sensitive. J Biol Chem 1991; 266:18217-23.
3. Borchelt DR, Taraboulos A, Prusiner SB. Evidence for synthesis of scrapie prion protein in the endocytic pathway. J Biol Chem 1992; 267:16188-99.
4. Marijanovic Z, Caputo A, Campana V, Zurzolo C. Identification of an intracellular site of prion conversion. PLoS Pathog 2009; 5:1000426.
5. Kaneko K, Vey M, Scott M, Pilkuhn S, Cohen FE, Prusiner SB. COOH-terminal sequence of the cellular prion protein directs subcellular trafficking and controls conversion into the scrapie isoform. Proc Natl Acad Sci USA 1997; 94:2333-8.
6. Taraboulos A, Scott M, Semenov A, Avraham D, Laszlo L, Prusiner SB. Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform. J Cell Biol 1995; 129:121-32.
7. Baron GS, Wehrly K, Dorward DW, Chesebro B, Caughey B. Conversion of raft associated prion protein to the protease-resistant state requires insertion of PrP-res (PrP(Sc)) into contiguous membranes. EMBO J 2002; 21:1031-40.
8. Baron GS, Caughey B. Effect of glycosylphosphatidylinositol anchor-dependent and -independent prion protein association with model raft membranes on conversion to the protease-resistant Isoform. J Biol Chem 2003; 278:14883-92.
9. Campana V, Sarnataro D, Zurzolo C. The highways and byways of prion protein trafficking. Trends Cell Biol 2005; 15:102-11.
10. Kocisko DA, Come JH, Priola SA, Chesebro B, Raymond GJ, Lansbury PT, et al. Cell free formation of protease resistant prion protein. Nature 1994; 370:471-4.
11. Deleault NR, Harris BT, Rees JR, Supattapone S. Formation of native prions from minimal components in vitro. Proc Natl Acad Sci USA 2007; 104:9741-6.
12. Kirby L, Birkett CR, Rudyk H, Gilbert IH, Hope J. In vitro cell-free conversion of bacterial recombinant PrP to PrPres as a model for conversion. J Gen Virol 2003; 84:1013-20.
13. Colby DW, Zhang Q, Wang S, Groth D, Legname G, Riesner D, et al. Prion detection by an amyloid seeding assay. Proc Natl Acad Sci USA 2007; 104:20914-9.
14. Atarashi R, Moore RA, Sim VL, Hughson AG, Dorward DW, Onwubiko HA, et al. Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein. Nat Methods 2007; 4:645-50.
15. Legname G, Baskakov IV, Nguyen HO, Riesner D, Cohen FE, DeArmond SJ, et al. Synthetic mammalian prions. Science 2004; 305:673-6.
16. Chesebro B, Trifilo M, Race R, Meade-White K, Teng C, LaCasse R, et al. Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 2005; 308:1435-9.
17. McNally KL, Ward AE, Priola SA. Cells expressing anchorless prion protein are resistant to scrapie infection. J Virol 2009; 83:4469-75.
18. Baron GS, Magalhaes AC, Prado MA, Caughey B. Mouse-adapted scrapie infection of SN56 cells: greater efficiency with microsome-associated versus purified PrP-res. J Virol 2006; 80:2106-17.
19. Magalhaes AC, Baron GS, Lee KS, Steele-Mortimer O, Dorward D, Prado MA, et al. Uptake and neuritic transport of scrapie prion protein coincident with infection of neuronal cells. J Neurosci 2005; 25:5207-16.
20. Gousset K, Schiff E, Langevin C, Marijanovic Z, Caputo A, Browman DT, et al. Prions hijack tunnelling nanotubes for intercellular spread. Nat Cell Biol 2009; 11:328-36.
21. Greil CS, Vorberg IM, Ward AE, Meade-White KD, Harris DA, Priola SA. Acute cellular uptake of abnormal prion protein is cell type and scrapie-strain independent. Virology 2008; 379:284-93.
22. Hijazi N, Kariv-Inbal Z, Gasset M, Gabizon R. PrPSc incorporation to cells requires endogenous glycosaminoglycan expression. J Biol Chem 2005; 280:17057-61.
23. Sc does not mediate internalization of PrPSc but is required at an early stage for de novo prion infection of Rov cells. J Virol 2007; 81:10786-91.
24. Vorberg I, Raines A, Priola SA. Acute formation of protease-resistant prion protein does not always lead to persistent scrapie infection in vitro. J Biol Chem 2004; 279:29218-25.
25. Ghaemmaghami S, Phuan PW, Perkins B, Ullman J, May BC, Cohen FE, et al. Cell division modulates prion accumulation in cultured cells. Proc Natl Acad Sci USA 2007; 104:17971-6.
26. Kanu N, Imokawa Y, Drechsel DN, Williamson RA, Birkett CR, Bostock CJ, et al. Transfer of scrapie prion infectivity by cell contact in culture. Curr Biol 2002; 12:523-30.
27. Paquet S, Langevin C, Chapuis J, Jackson GS, Laude H, Vilette D. Efficient dissemination of prions through preferential transmission to nearby cells. J Gen Virol 2007; 88:706-13.
28. Fevrier B, Vilette D, Archer F, Loew D, Faigle W, Vidal M, et al. Cells release prions in association with exosomes. Proc Natl Acad Sci USA 2004; 101:9683-8.
29. Mishra RS, Basu S, Gu Y, Luo X, Zou WQ, Mishra R, et al. Protease-resistant human prion protein and ferritin are cotransported across Caco-2 epithelial cells: implications for species barrier in prion uptake from the intestine. J Neurosci 2004; 24:11280-90.
30. Brandner S, Isenmann S, Raeber A, Fischer M, Sailer A, Kobayashi Y, et al. Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 1996; 379:339-43.
31. Blattler T, Brandner S, Raeber AJ, Klein MA, Voigtlander T, Weissmann C, et al. PrP-expressing tissue required for transfer of scrapie infectivity from spleen to brain. Nature 1997; 389:69-73.
32. Glatzel M, Aguzzi A. PrP(C) expression in the peripheral nervous system is a determinant of prion neuroinvasion. J Gen Virol 2000; 81:2813-21.
33. Race R, Oldstone M, Chesebro B. Entry versus blockade of brain infection following oral or intraperitoneal scrapie administration: Role of prion protein expression in peripheral nerves and spleen. J Virol 2000; 74:828-33.
34. Vorberg I, Raines A, Story B, Priola SA. Susceptibility of common fibroblast cell lines to transmissible spongiform encephalopathy agents. J Infect Dis 2004; 189:431-9.
35. Glatzel M, Aguzzi A. Peripheral pathogenesis of prion diseases. Microbes Infect 2000; 2:613-9.
36. Follet J, Lemaire-Vieille C, Blanquet-Grossard F, Podevin-Dimster V, Lehmann S, Chauvin JP, et al. PrP expression and replication by Schwann cells: implications in prion spreading. J Virol 2002; 76:2434-9.
37. Groschup MH, Beekes M, McBride PA, Hardt M, Hainfellner JA, Budka H. Deposition of disease-associated prion protein involves the peripheral nervous system in experimental scrapie. Acta Neuropathol 1999; 98:453-7.
38. Hainfellner JA, Budka H. Disease associated prion protein may deposit in the peripheral nervous system in human transmissible spongiform encephalopathies. Acta Neuropathol 1999; 98:458-60.
39. Kratzel C, Kruger D, Beekes M. Prion propagation in a nerve conduit model containing segments devoid of axons. J Gen Virol 2007; 88:3479-85.
40. Vorberg I, Priola SA. Molecular basis of scrapie strain glycoform variation. J Biol Chem 2002; 277:36775-81.
41. Beekes M, McBride PA. The spread of prions through the body in naturally acquired transmissible spongiform encephalopathies. FEBS J 2007; 274:588-605.
42. Weller RO. Pathology of cerebrospinal fluid and interstitial fluid of the CNS: significance for Alzheimer disease, prion disorders and multiple sclerosis. J Neuropathol Exp Neurol 1998; 57:885-94.